title: Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma.
authors: Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
authors: F
authors: F
authors: McClanahan
authors: T
authors: T
authors: Hielscher
authors: M
authors: M
authors: Rieger
authors: M
authors: M
authors: Hensel
authors: M
authors: M
authors: Bentz
authors: I
authors: I
authors: Schmidt-Wolf
authors: A
authors: A
authors: Käbisch
authors: H
authors: H
authors: Salwender
authors: H
authors: H
authors: Dürk
authors: H
authors: H
authors: Staiger
authors: T
authors: T
authors: Mandel
authors: K
authors: K
authors: Neben
authors: J
authors: J
authors: Hillengass
authors: E
authors: E
authors: Leo
authors: A
authors: A
authors: Krämer
authors: A D
authors: AD
authors: Ho
authors: M
authors: M
authors: Witzens-Harig
mesh_terms: D000328:Adult; D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D014408:Biomarkers, Tumor; D003362:Cost-Benefit Analysis; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D006801:Humans; D053208:Kaplan-Meier Estimate; D008224:Lymphoma, Follicular / Q000188:drug therapy* / Q000191:economics / Q000235:genetics; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D016016:Proportional Hazards Models; D012074:Remission Induction; D000069283:Rituximab; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D055815:Young Adult
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D014408:Biomarkers, Tumor; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone